Predictive phosphoproteomic signatures for midostaurin plus chemotherapy response in FLT3 mutant positive acute myeloid leukaemia
Dokal, Arran David, Arruda, Andrea, Smith, Ryan, Greenhalgh, Calum, Patella, Francesca, Casado-Izquierdo, Pedro Maria, Wrench, Bela, Theaker, Jane, Thompson, Andrew, Minden, Mark D., Gribben, John G., Britton, David James, Cutillas, Pedro Rodriguez
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Abstract LBA013: Phosphoproteomics reveals active drug targets on pathways of resistance and predicts response to midostaurin plus chemotherapy in FLT3 mutant-positive acute myeloid leukemia
Nobre, Luis Veiga, Basanta, Celia Colomina, Pedicona, Salvatore Federico, Dokal, Arran David, Arruda, Andrea, Smith, Ryan, Greenhalgh, Calum, Patella, Francesca, Casado-Izquierdo, Pedro Maria, Wrench, Bela, Theaker, Jane, Thompson, Andrew, Minden, Mark D., Gribben, John G., Britton, David James, Cutillas, Pedro Rodriguez
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
SEQUENTIAL TREATMENTS AND BIOMARKERS TO REVERSE RESISTANCE TO KINASE INHIBITORS
PEDICONA, Federico, CASADO-IZQUIERDO, Pedro Maria, CUTILLAS, Pedro Rodriguez, HIJAZI, Maruan
Year of Publication 28.08.2024
Get full text
Year of Publication 28.08.2024
Patent
SEQUENTIAL TREATMENTS AND BIOMARKERS TO REVERSE RESISTANCE TO KINASE INHIBITORS
PEDICONA, Federico, CASADO-IZQUIERDO, Pedro Maria, CUTILLAS, Pedro Rodriguez, HIJAZI, Maruan
Year of Publication 27.04.2023
Get full text
Year of Publication 27.04.2023
Patent